coated tablet contains 40 mg of Febuxostat
coated tablet contains 80 mg of Febuxostat
Hyperuricemia, there by prevent the occurence of Uric acid
Recommended dosage in hyperuricemia: 40 mg
or 80 mg OD.
Starting dose: 40 mg OD;
sUA < 6 mg/dL, not achieved after 2
weeks with 40 mg, Febuxostat 80 mg is recommended.
It can be taken without regard to
food or antacid use.
Mechanism of action
Inhibits both oxidised and reduced forms of
Relatively strong inhibitor of
Xanthine oxidase compared to Allopurinol
hyperuricemia and prevent the progression to chronic uric acid
with 10 capsules in each strip
progression to chronic urate nephropathy